These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 7284070)

  • 1. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
    Rotthauwe HW; Kowalewski S
    Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of normal daughters' and sisters' creatine kinase levels in estimating heterozygosity in Duchenne muscular dystrophy.
    Emery AE; Holloway S
    Hum Hered; 1977; 27(2):118-26. PubMed ID: 863458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUCHEN: an interactive computer program for calculating heterozygosity (carrier) risks in X-linked recessive lethal diseases, and its application in Duchenne muscular dystrophy.
    Andrews DF; Brasher PM; Manchester KE; Percy ME; Rusk AC; Soltan HC; Trueman DW
    Am J Med Genet; 1986 Oct; 25(2):211-8. PubMed ID: 3777018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic counseling in Becker type X-linked muscular dystrophy. II: Practical considerations.
    Grimm T
    Am J Med Genet; 1984 Aug; 18(4):719-23. PubMed ID: 6486170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A family of scapula-back type of x-linked recessive muscular dystrophy].
    Ji XW
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):136-8, 190. PubMed ID: 2591265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
    Muir WA; Knoke J; Martin A; Vignos P; McErlean A
    Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling.
    Bushby K; Goodship J; Haggerty D; Heald A; Walls T
    Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338
    [No Abstract]   [Full Text] [Related]  

  • 9. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
    Zatz M; Frota-Pessoa O; Levy JA; Peres CA
    J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic counseling of isolated carriers of Duchenne muscular dystrophy.
    Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P
    Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimate of the proportion of Duchenne muscular dystrophy with autosomal recessive inheritance.
    Zatz M; Passos-Bueno MR; Rapaport D
    Am J Med Genet; 1989 Mar; 32(3):407-10. PubMed ID: 2658592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serum creatine kinase estimation with short tandem repeats based linkage analysis in carriers and affected children of Duchenne muscular dystrophy.
    Hashim R; Shaheen S; Ahmad S; Sattar A; Khan FA
    J Ayub Med Coll Abbottabad; 2011; 23(1):125-8. PubMed ID: 22830166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carrier detection and gene analysis in a Duchenne muscular dystrophy family].
    Lu FM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Aug; 23(4):231-3, 255. PubMed ID: 1979269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study.
    Hutton EM; Thompson MW
    Can Med Assoc J; 1976 Oct; 115(8):749-52. PubMed ID: 974964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1981; 8(4):397-409. PubMed ID: 7246612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duchenne muscular dystrophy in a girl with a 45,X/46,XX/47,XXX chromosome constitution.
    Bortolini ER; da Silva DM; Chequer RS; Vianna-Morgante AM; Zatz M
    Am J Med Genet; 1986 Oct; 25(2):239-43. PubMed ID: 3777022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of DNA probes to carrier detection and prenatal diagnosis of Duchenne (and Becker) muscular dystrophy.
    Mulley JC; Gedeon AK; Haan EA; Sheffield LJ; White SJ; Bates LJ; Robertson EF; Sutherland GR
    Aust Paediatr J; 1988; 24 Suppl 1():92-7. PubMed ID: 3202740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Muscle LDH isoenzymes in neuromuscular diseases and in carriers of recessive X-linked muscular dystrophy (duchenne)].
    Kowalewski S; Rotthauwe HW
    Z Kinderheilkd; 1972; 113(1):55-70. PubMed ID: 5056500
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
    Zatz M; Otto PA
    Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.